drugset / Trial / NCT02084511

Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain

NCT02084511

Phase 1 Completed 80 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effectiveness of BI 1026706 powder for reconstitution of an oral solution compared to placebo and the relative effectiveness compared to Celecoxib.

Timeline

Start
2014-03
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1026706 Unknown Oral
Subject Celecoxib Other / unclassified

Indications

No indication recorded.